Compare Cytokinetics Inc (CYTK) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Nucor Corporation — how do they compare? Cytokinetics Inc trades at $76.67 (market cap $10.63B), while Nucor Corporation trades at $271.95 (market cap $61.93B). The key difference: Nucor Corporation is far larger — about 5.8× Cytokinetics Inc's market cap, and Nucor Corporation pays a 0.82% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | NUE | |
|---|---|---|
Market Cap | $10.63B | $61.93B |
Sector | Technology | Basic Materials |
52-Week High | $87.26 | $274.74 |
52-Week Low | $34.31 | $131.78 |
Enterprise Value | $10.74B | $66.34B |
Dividend Yield | — | 0.82% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
